Surveillance of the liver in type 2 diabetes: important but unfeasible
Source : https://pubmed.ncbi.nlm.nih.gov/38334817/
Fatty liver plays a pivotal role in the pathogenesis of the metabolic syndrome and type 2 diabetes. According to an updated classification, any individual with liver steatosis and one or...
Early detection of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes is crucial, emphasizing the need for more accurate screening strategies and effective management through weight loss interventions and emerging fibrosis biomarkers.
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians
Source : https://pubmed.ncbi.nlm.nih.gov/38639549/
American College of Physicians. (PROSPERO: CRD42022322129).
In adults with T2DM, SGLT2 inhibitors and GLP1 agonists (but not DPP4 inhibitors, insulin, or tirzepatide) reduce all-cause mortality and MACE compared with usual care.
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38363342/
This systematic review was registered on PROSPERO (ID CRD42023418005).
CGM use compared with SMBG is associated with improvements in glycaemic control in adults with type 2 diabetes. However, all studies were open label. In addition, outcome data on incident severe hypoglycaemia and incident microvascular and macrovascular complications were scarce.
Remission of type 2 diabetes: always more questions, but enough answers for action
Source : https://pubmed.ncbi.nlm.nih.gov/38189935/
The concept of type 2 diabetes remission is evolving rapidly, and gaining wide public and professional interest, following demonstration that with substantial intentional weight loss almost nine in ten people...
Intentional weight loss >10-15 kg can lead to type 2 diabetes remission, improving HbA1c and metabolic health. Early intervention and sustainable weight management are crucial for long-term success.
Prediabetes and poorly controlled type-2 diabetes as risk indicators for peri-implant diseases:A systematic review and meta-analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38788918/
Clinicians should measure blood HbA1c levels when planning implant-supported restorations, thus patients with undiagnosed or poorly controlled type-2 diabetes can be identified, that allows for glycemic level adjustment prior to...
Patients with poorly controlled type-2 diabetes or prediabetes may have worse peri-implant conditions compared to patients without diabetes and well-controlled type-2 diabetes. Well-controlled type-2 diabetes is not a risk indicator for peri-implant diseases.